Credit Agricole S A Moderna, Inc. Call Options Transaction History

Credit Agricole S A

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $26.5 Million - $35.8 Million	-310,169 Reduced 69.8%	134,213 $14.3 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $28.6 Million - $43 Million	411,882 Added 1267.33%	444,382 $44.2 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $1.93 Million - $2.53 Million	20,000 Added 160.0%	32,500 $3.36 Million
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $1.48 Million - $2.01 Million	12,500 New	12,500 $1.52 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $1.26 Million - $2.35 Million	10,000 New	10,000 $1.72 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.